Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang 443002, P. R. China.
Hubei Three Gorges Laboratory, Yichang 443007, P. R. China.
J Org Chem. 2024 Jun 21;89(12):8815-8827. doi: 10.1021/acs.joc.4c00698. Epub 2024 Jun 4.
-Glycosides are more resistant to enzymatic and chemical hydrolysis and exhibit higher metabolic stability than common -glycosides, demonstrating their widespread application in biological research and drug development. In particular, β--glycosides are used as antirheumatic, anticancer, and antidiabetic drugs in clinical practice. However, the stereoselective synthesis of β--glycosides is still highly challenging. Herein, we report an effective β--glycosylation using 3--trichloroacetimidoyl glycal and thiols under mild conditions. The C3-imidate is designed to guide Pd to form a complex with glucal from the upper face, followed by Pd-S (thiols) coordination to realize β-stereoselectivity. This method demonstrates excellent compatibility with a broad scope of various thiol acceptors and glycal donors with yields up to 87% and a β/α ratio of up to 20:1. The present β--glycosylation strategy is used for late-stage functionalization of drugs/natural products such as estrone, zingerone, and thymol. Overall, this novel and simple operation approach provides a general and practical strategy for the construction of β-thioglycosides, which holds high potential in drug discovery and development.
糖苷比普通的 -糖苷更能抵抗酶解和化学水解,表现出更高的代谢稳定性,证明了它们在生物研究和药物开发中的广泛应用。特别是β--糖苷在临床上被用作抗风湿、抗癌和抗糖尿病药物。然而,β--糖苷的立体选择性合成仍然极具挑战性。在此,我们报告了一种使用 3--三氯乙酰亚胺基糖醛和硫醇在温和条件下进行有效β--糖苷化的方法。C3-亚氨基设计用于引导 Pd 从上面与葡萄糖形成配合物,然后 Pd-S(硫醇)配位以实现β-立体选择性。该方法与各种硫醇受体和糖醛供体具有广泛的适用性,产率高达 87%,β/α 比高达 20:1。该β--糖苷化策略用于雌酮、生姜酮和百里酚等药物/天然产物的后期功能化。总的来说,这种新颖而简单的操作方法为β-硫代糖苷的构建提供了一种通用且实用的策略,在药物发现和开发中具有很高的潜力。